Pfizer Inc. PFE
Regular-session close
After hours · Nov 17, 7:59 PM ET
- YTD
- +14.34%
- 1 year
- +13.52%
Discussion (1891)
@fitoto: you’re missing one big fact-
Covid infections only count if they occur after one week of 2nd shot. Meaning if you were among placebo group and you caught Covid before day 28 (of first shot) then that result is thrown out.
That would also mean the people who got a second shot this week wouldn’t count, since they too have to wait a week after that shot.
So if Pfizer picked really high infections areas that could work against them because it would effectively cause multiple people to get disqualified.
No such thing- I would be seeing that all over the internet. Nobody has claimed any rescheduling.
This will go up before close and finish at 36.50
Loaded more options. Jan call. 40 strike
Going up soon. Vaccine news is coming tomorrow after election day......
Add more options. This will go high soon
Updates on COVID-19 Progress
Data Monitoring Committee has NOT conducted any interim efficiency analyses to date
Assuming positive data, expect to apply for U.S EUA soon after safety milestone, which they expect to be 3rd week of November.
Expect to have manufacturing data ready for submission before safety milestone is reached
Check out the slides- ‘- Data Monitoring Committee has not conducted any interim efficacy analyses to date’
Money maker! Check out LCA!
Abbet and COVX make tests.
